These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 20548092)

  • 1. Genomic instability after allogeneic hematopoietic cell transplantation is frequent in oral mucosa, particularly in patients with a history of chronic graft-versus-host disease, and rare in nasal mucosa.
    Khan FM; Sy S; Louie P; Ugarte-Torres A; Berka N; Sinclair GD; Stewart DA; Russell JA; Storek J
    Blood; 2010 Sep; 116(10):1803-6. PubMed ID: 20548092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Chronic graft-versus-host-disease involving the oral mucosa: clinical presentation and treatment].
    Elad S; Levitt M; M Y S
    Refuat Hapeh Vehashinayim (1993); 2008 Nov; 25(4):19-27, 72. PubMed ID: 19263864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histopathological Grading of Oral Mucosal Chronic Graft-versus-Host Disease: Large Cohort Analysis.
    Tollemar V; Tudzarovski N; Warfvinge G; Yarom N; Remberger M; Heymann R; Garming Legert K; Sugars RV
    Biol Blood Marrow Transplant; 2020 Oct; 26(10):1971-1979. PubMed ID: 32659433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and histopathological features of the oral mucosa in allogeneic haematopoietic stem cell transplantation patients.
    Demarosi F; Lodi G; Carrassi A; Moneghini L; Sarina B; Sardella A
    Exp Oncol; 2007 Dec; 29(4):304-8. PubMed ID: 18199988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dendritic cell chimerism in oral mucosa of transplanted patients affected by graft-versus-host disease.
    Pérez CA; Rabanales R; Rojas-Alcayaga G; Larrondo M; Escobar AF; López MN; Salazar-Onfray F; Alfaro JI; González FE
    J Oral Pathol Med; 2016 Feb; 45(2):127-35. PubMed ID: 26102283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MASCC/ISOO Clinical Practice Statement: The risk of secondary oral cancer following hematopoietic cell transplantation.
    Raber-Durlacher JE; Treister NS; Zadik Y; Dean DR; Miranda-Silva W; Fregnani ER; Epstein JB; Elad S
    Support Care Cancer; 2024 Jul; 32(8):545. PubMed ID: 39048762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extensive dental caries in patients with oral chronic graft-versus-host disease.
    Castellarin P; Stevenson K; Biasotto M; Yuan A; Woo SB; Treister NS
    Biol Blood Marrow Transplant; 2012 Oct; 18(10):1573-9. PubMed ID: 22516054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychological and physical function in allogeneic hematopoietic cell transplant survivors with chronic graft-versus-host disease.
    Hansen JL; Juckett MB; Foster MA; Rumble ME; Morris KE; Hematti P; Costanzo ES
    J Cancer Surviv; 2023 Jun; 17(3):646-656. PubMed ID: 36917433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of cGVHD on socioeconomic outcomes in survivors with pediatric hematopoietic stem cell transplant in Japan: a cross-sectional observational study.
    Soejima T; Shiohara M; Ishida Y; Inoue M; Hayakawa A; Sato A; Kamibeppu K; Atsuta Y; Yamashita T
    Int J Hematol; 2021 Apr; 113(4):566-575. PubMed ID: 33386599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continuing increased risk of oral/esophageal cancer after allogeneic hematopoietic stem cell transplantation in adults in association with chronic graft-versus-host disease.
    Atsuta Y; Suzuki R; Yamashita T; Fukuda T; Miyamura K; Taniguchi S; Iida H; Uchida T; Ikegame K; Takahashi S; Kato K; Kawa K; Nagamura-Inoue T; Morishima Y; Sakamaki H; Kodera Y;
    Ann Oncol; 2014 Feb; 25(2):435-41. PubMed ID: 24399081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk Factors and Outcome of Chronic Graft-versus-Host Disease after Allogeneic Stem Cell Transplantation-Results from a Single-Center Observational Study.
    Grube M; Holler E; Weber D; Holler B; Herr W; Wolff D
    Biol Blood Marrow Transplant; 2016 Oct; 22(10):1781-1791. PubMed ID: 27343720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequent genomic alterations in epithelium measured by microsatellite instability following allogeneic hematopoietic cell transplantation in humans.
    Faber P; Fisch P; Waterhouse M; Schmitt-Gräff A; Bertz H; Finke J; Spyridonidis A
    Blood; 2006 Apr; 107(8):3389-96. PubMed ID: 16368884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of chronic graft-versus-host disease on the health status of hematopoietic cell transplantation survivors: a report from the Bone Marrow Transplant Survivor Study.
    Fraser CJ; Bhatia S; Ness K; Carter A; Francisco L; Arora M; Parker P; Forman S; Weisdorf D; Gurney JG; Baker KS
    Blood; 2006 Oct; 108(8):2867-73. PubMed ID: 16788100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic graft versus host disease of oral mucosa: review of available therapies.
    Imanguli MM; Pavletic SZ; Guadagnini JP; Brahim JS; Atkinson JC
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Feb; 101(2):175-83. PubMed ID: 16448918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Occurrence and Severity of Donor Lymphocyte Infusion-Associated Chronic Graft-versus-Host Disease Influence the Clinical Outcomes in Relapsed Acute Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation.
    Yu WJ; Mo XD; Zhang XH; Xu LP; Wang Y; Yan CH; Chen H; Chen YH; Han W; Wang FR; Wang JZ; Liu KY; Huang XJ
    Biol Blood Marrow Transplant; 2019 May; 25(5):912-920. PubMed ID: 30485788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Healthcare resource utilization and costs associated with acute graft-versus-host disease following allogeneic hematopoietic cell transplantation.
    Yu J; Lal L; Anderson A; DuCharme M; Parasuraman S; Weisdorf D
    Support Care Cancer; 2020 Nov; 28(11):5491-5499. PubMed ID: 32172407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral Chronic Graft-versus-Host Disease and Oral Health after Allogeneic Hematopoietic Cell Transplantation - What the Care Team Needs to Know.
    Laheij AMGA; Fregnani ER; de Macedo LD; Treister NS
    Transplant Cell Ther; 2024 Sep; 30(9S):S548-S558. PubMed ID: 39370236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinctive clinical characteristics and favorable outcomes in patients with large granular lymphocytosis after allo-HCT: 12-year follow-up data.
    Poch Martell M; Hamad N; Shin E; Moon JH; Sohn SK; Uhm J; Michelis FV; Viswabandya A; Lipton JH; Messner HA; Kim DDH
    Eur J Haematol; 2017 Aug; 99(2):160-168. PubMed ID: 28449187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of pre-transplant depression on outcomes of allogeneic and autologous hematopoietic stem cell transplantation.
    El-Jawahri A; Chen YB; Brazauskas R; He N; Lee SJ; Knight JM; Majhail N; Buchbinder D; Schears RM; Wirk BM; Wood WA; Ahmed I; Aljurf M; Szer J; Beattie SM; Battiwalla M; Dandoy C; Diaz MA; D'Souza A; Freytes CO; Gajewski J; Gergis U; Hashmi SK; Jakubowski A; Kamble RT; Kindwall-Keller T; Lazarus HM; Malone AK; Marks DI; Meehan K; Savani BN; Olsson RF; Rizzieri D; Steinberg A; Speckhart D; Szwajcer D; Schoemans H; Seo S; Ustun C; Atsuta Y; Dalal J; Sales-Bonfim C; Khera N; Hahn T; Saber W
    Cancer; 2017 May; 123(10):1828-1838. PubMed ID: 28102896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pre-engraftment graft-versus-host disease after allogeneic hematopoietic cell transplantation for acute leukemia.
    Lee JH; Lee JH; Kim DY; Yun SC; Kim SD; Choi Y; Lee YS; Kang YA; Jeon MJ; Seol M; Lee KH
    Eur J Haematol; 2011 Aug; 87(2):172-81. PubMed ID: 21599753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.